risks of compounded semaglutide "semaglutide" is not FDA-approved Navigating Compounded Semaglutide: What Health

Weight loss continues at a rate of 1 to 2 pounds per week

Gastrointestinal Disorders: Conditions like Crohn's disease, celiac disease, or a history of weight-loss surgery (like gastric bypass) can damage the exact parts of the intestine that are in charge of B12 absorption

A simple 2030 minute walk can help your body get your intestines moving

Patients may consider GLP-1 agonist solely as a Weightloss drug hence not disclosing usage

Wilson et al

Subcutaneous injection (compounded prescription) Published clinical protocols report typical dose ranges of 1 to 3 mg subcutaneously, administered daily or several times per week, adjusted for the individual patient by their prescribing provider